
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
γF-crystallin CRISPR/Cas9 KO Plasmid (m) | sc-419833 | 20 µg | $397.00 |
Crygf encodes γF-crystallin, a highly abundant structural crystallin in the mouse ocular lens that supports refractive index, transparency, and long-term fiber cell stability. γ-crystallins are characterized by tightly packed β-sheet domains that contribute to high protein density while minimizing light scattering, and their maintenance depends on lens proteostasis networks including chaperone interactions, redox balance, and limited protein turnover. Perturbation of crystallin composition or solubility can disrupt lens architecture, promote protein aggregation, and increase susceptibility to cataract-like opacity phenotypes in experimental models. Crygf therefore serves as a useful node for studying lens development, fiber cell differentiation, and mechanisms of protein stability in a largely post-mitotic tissue context.
γF-crystallin CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Crygf gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Crygf together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Crygf open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish γF-crystallin protein expression.
This CRISPR knockout system enables efficient generation of Crygf-deficient cell models for investigation of γF-crystallin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.